NEW YORK (360Dx) — Owlstone Medical and the University of Manchester announced today that they have partnered on the development of a breath-based diagnostic for asthma with funding from British research organizations Asthma UK and Innovate UK.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.